Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 601,482 shares at $56.01 ($33.3M) on 2022-07-07, disclosed to the SEC on 2022-07-07.
Open-market sale of $33.3M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.27 | 32,486 | $1.7M | 5.1% |
| 2 | $52.27 | 32,486 | $1.7M | 5.1% |
| 3 | $55.26 | 87,417 | $4.8M | 14.5% |
| 4 | $55.26 | 87,417 | $4.8M | 14.5% |
| 5 | $56.01 | 180,838 | $10.1M | 30.4% |
| 6 | $56.01 | 180,838 |
| $10.1M |
| 30.4% |
| Total | $55.39 avg | 601,482 | $33.3M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |